title: A modulatory role of endogenous opioids on prolactin secretion at the end of pregnancy in the rat.
abstract: It is well known that the fall in serum progesterone concentrations during late pregnancy induces prolactin secretion in rats. On day 19 of pregnancy, administration of 10 mg of the antiprogesterone RU-486/kg induced a small but significant increase in serum prolactin. A lower dose (2 mg/kg) was not effective. Administration of naloxone (2 mg/kg) to pregnant rats on day 19 of pregnancy did not modify circulating prolactin but, after RU-486 treatment, a notable increase in serum prolactin was obtained 30 min after naloxone was given. The lack of effect of naloxone-methobromide in pregnant rats pretreated with RU-486 may indicate that the opioid-induced prolactin suppression acts centrally, most probably at the hypothalamic level. During day 21 of pregnancy, the time-course of prolactin secretion, measured at 0900, 1400, 1900 and 2200 h, was inversely correlated with circulating progesterone levels. At 0900 h, serum prolactin was very low with high serum progesterone concentrations but a significant increase in serum prolactin occurred at 2200 h; this was coincident with a significant decrease in the steroid. The stimulatory effect of naloxone on prolactin secretion was clearly dependent on the circulating progesterone level. Thus, at 1900 h of day 21, naloxone induced a significant increase in serum prolactin but, at 2200 h, the opioid antagonist dramatically enhanced the circulating level of prolactin. The serum prolactin increase induced by naloxone at 1900 h was prevented by the s.c. administration of 5 mg progesterone given 7 h earlier.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Laboratorio de Reproducción y Lactancia, CRICYT-CONICET, Mendoza, Argentina.
authors.forename: M
authors.initials: M
authors.lastname: Soaje
authors.forename: R P
authors.initials: RP
authors.lastname: Deis
mesh_terms: D000818:Animals; D001971:Bromocriptine / Q000494:pharmacology; D004723:Endorphins / Q000502:physiology*; D005260:Female; D005865:Gestational Age; D015735:Mifepristone / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D010111:Oxymorphone / Q000494:pharmacology; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000502:physiology*; D011359:Proestrus / Q000097:blood; D011374:Progesterone / Q000097:blood; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D004723:Endorphins; D015735:Mifepristone; D009270:Naloxone; D001971:Bromocriptine; D011374:Progesterone; D011388:Prolactin; D010111:Oxymorphone